» Articles » PMID: 34143206

DUSP4 Promotes the Carcinogenesis of CCRCC Via Negative Regulation of Autophagic Death

Overview
Date 2021 Jun 18
PMID 34143206
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

DUSP4 is considered as an oncogenic gene. However, the effect of DUSP4 on the carcinogenesis of clear cell Renal cell carcinoma (CCRCC) is still unclear. In this study, DUSP4 mRNA levels were significantly increased in CCRCC tissues and cell lines. Furthermore, DUSP4 overexpression promotes the proliferation, migration, and tumorigenicity of CCRCC cells while DUSP4 silencing showed the opposite effects. Importantly, both autophagic activity (LC3 conversion rate and LC3 puncta formation) and total death level promoted by DUSP4 silencing were reversed by treatment with 3-MA in CCRCC cells. Moreover, the proliferation and migration of CCRCC cells inhibited by DUSP4 silencing were also recovered by suppression of autophagy with 3-MA. In conclusion, DUSP4 serves as an oncogenic gene in CCRCC carcinogenesis due to its inhibitory effect on autophagic death, indicating the potential value of DUSP4 in the diagnosis and treatment of CCRCC.

Citing Articles

ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.

Lin S, Chen Q, Tan C, Su M, Min L, Ling L BMC Med Genomics. 2024; 17(1):153.

PMID: 38840097 PMC: 11151722. DOI: 10.1186/s12920-024-01895-7.


Dual-Specificity Phosphatase 4 Promotes Malignant Features in Colorectal Cancer Through Cyclic-AMP Response Element Binding Protein/Protein Kinase CAMP-Activated Catalytic Subunit Beta Activation.

Pei W, Yin W, Yu T, Zhang X, Zhang Q, Yang X Dig Dis Sci. 2024; 69(8):2856-2874.

PMID: 38824257 DOI: 10.1007/s10620-024-08481-y.


DUSP4 maintains the survival and LSD1 protein stability in esophageal squamous cell carcinoma cells by inhibiting JNK signaling-dependent autophagy.

Liu X, Ye Z, Rao D, Chen Q, Zhang Z In Vitro Cell Dev Biol Anim. 2024; 60(2):115-122.

PMID: 38286920 DOI: 10.1007/s11626-023-00845-4.


Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer.

Hou Z, Lin J, Ma Y, Fang H, Wu Y, Chen Z Front Pharmacol. 2023; 14:1193791.

PMID: 37324492 PMC: 10267405. DOI: 10.3389/fphar.2023.1193791.


Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.

Liu Y, Shi Z, Zheng J, Zheng Z, Sun H, Xuan Z Front Immunol. 2023; 14:1171883.

PMID: 37056778 PMC: 10086373. DOI: 10.3389/fimmu.2023.1171883.